DUBLIN--(BUSINESS WIRE)--The "Translational Regenerative Medicine Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2023" report has been added to ResearchAndMarkets.com's offering.
The report predicts the global translational regenerative medicine market to grow with a CAGR of 12.5% over the forecast period of 2017-2023. The study on translational regenerative medicine market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific and RoW for the period of 2015 to 2023.
The report on translational regenerative medicine market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global translational regenerative medicine market over the period of 2015 to 2023.
Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global translational regenerative medicine market over the period of 2015 to 2023. Further, Growth Matrix given in the report brings an insight on the investment areas that existing or new market players can consider.
Key Topics Covered
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
2. Executive Summary
3. Global Translational Regenerative Medicine Market Overview
3.2. Market Dynamics
3.3. Porter's Five Forces Analysis
3.4. Growth Matrix Analysis
3.5. Competitive Landscape in the Global Translational Regenerative Medicine Market
4. Global Translational Regenerative Medicine Market by Product Type
4.1. Tissue Engineered Products
4.2. Cell Based Products
4.3. Gene Therapy Products
5. Global Translational Regenerative Medicine Market by Application
6. Global Translational Regenerative Medicine Market by Region 2017-2023
6.1. North America
7. Company Covered
7.1. Anika Therapeutics
7.2. Nuvasive, Inc.
7.3. Orthofix International N.V
7.5. Athersys, Inc.
7.6. Celgene Corporation
7.7. Vericel Corporation
7.9. Brainstorm Cell Therapeutics Inc.
7.10. Gamida Cell Ltd.
For more information about this report visit https://www.researchandmarkets.com/research/ll75g6/global?w=4